ArticleFrontiers in medicine2025
Case Report: Endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of esophageal tuberculosis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To summarise the characteristics of esophageal tuberculosis, and to evaluate the role of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in the diagnosis of esophageal tuberculosis. Methods: A retrospective analysis of esophageal tuberculosis patients diagnosed by the EUS-FNB between May 2012 and August 2023 was reported. Final diagnosis was based on histopathology, clinical context in combination with response to antitubercular therapy. Tissue acquisition of both esophageal lesions and enlarged mediastinal lymph nodes was performed by EUS-FNB. The variables evaluated were clinical features, location and diameter of the esophageal lesions and enlarged lymph nodes. Results: Six esophageal tuberculosis patients without surgical management were finally identified by the performance of EUS-FNB. The most common clinical feature was progressive dysphagia. The site of lesions was most common located in the middle of esophagus (66.7%). Diameter of lesions range from 1.2 to 4.1 cm. Multiple enlarged mediastinal lymph nodes were of various sizes (range 0.6-1.6 cm in diameter). CT scan revealed focal thickened esophageal wall, esophageal stenosis, and a mass with moderate and heterogeneous enhancement in five patients (83.33%), which indicating esophageal carcinoma. Purified protein derivative (PPD) and T cell spot test (T-spot) were positive in four cases (66.7%), which were significant in the diagnosis. EUS-FNB provided the pathological diagnosis of tuberculosis in four cases. Conclusion: Esophageal tuberculosis should be distinguished from advanced esophageal carcinoma and leiomyoma. Moreover, EUS-FNB is an excellent method in both image and tissue biopsy to establish an accurate diagnosis of esophageal tuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.